| Bioactivity | CRAC intermediate 2 is a intermediate compound for CRAC inhibitor synthesis, extracted from patent WO 2013059666A1. | ||||||||||||
| Name | CRAC intermediate 2 | ||||||||||||
| CAS | 123066-64-8 | ||||||||||||
| Formula | C11H7F6N3 | ||||||||||||
| Molar Mass | 295.18 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
CRAC intermediate 2
CAS: 123066-64-8 F: C11H7F6N3 W: 295.18
CRAC intermediate 2 is a intermediate compound for CRAC inhibitor synthesis, extracted from patent WO 2013059666A1.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.